瘢痕子宫合并前置胎盘外周血血管内皮生长因子、可溶性酪氨酸激酶受体-1水平及意义

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the levels and significant of vascular endothelial growth factor(VEGF)and soluble tyrosine kinase receptor-1(sFIt-1)in peripheral blood of scarred uterus with placenta previa.Methods A total of 218 cases of pregnant women with scarred uterus treated in Wuxi Yihe Obstetrics and Gynecology Hospital from January 2019 to November 2020 were selected as the research subjects.Among them,76 pregnant women with placenta previa were taken as the observation group,and 142 pregnant women without placenta previa were taken as the control group.VEGF and SFIt-1 levels in the two groups were detected,Pearson was used to analyze the relationship between VEGF and SFIt-1 levels in peripheral blood of the observation group,and the maternal and infant outcomes of the two groups were compared.Results The VEGF in peripheral blood of the observation group was(71.60±24.66)ng/mL,which was lower than that of the control group of(192.41±35.57)ng/mL,the difference was statistically significant(P<0.05).The SFIt-1 of the observation group was(2.98±0.91)ng/mL,which was higher than that of the control group of(1.20±0.45)ng/mL,and the difference was statistically significant(P<0.05).The levels of VEGF and SFIt-1 in peripheral blood of pregnant women of scarred uterus with placenta previa were negatively correlated(r=-0.594,P<0.05).The incidence rates of cesarean section,postpartum hemorrhage,placenta implantation and hysterectomy in the observation group were 100.00%,38.16%,23.68% and 7.89%,respectively,which were higher than those in the control group(68.31%,12.68%,6.34% and 0.00%),the differences were statistically significant(P<0.05).The incidence rates of neonatal asphyxia and premature infants in the observation group were 19.74% and 64.47%,respectively,which were higher than those in the control group(4.23% and 35.92%),the differences were statistically significant(P<0.05).Conclusion There is a correlation between the decrease of VEGF and the increase of SFIt-1 in peripheral blood of pregnant women of scarred uterus with placenta previa,and the incidence of adverse pregnancy outcomes in pregnant women with scar uterus combined with placenta previa is higher.

Key words： Scared uterus Placenta previa Vascular endothelial growth factor Soluble tyrosine kinase receptor-1 Pregnancy outcome

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JIANG Li-rong
	HUANG Xiao-ping
	XU Yi-yu

Cite this article:

JIANG Li-rong,HUANG Xiao-ping,XU Yi-yu. Levels and significant of vascular endothelial growth factor and soluble tyrosine kinase receptor-1 in peripheral blood of scarred uterus with placenta previa[J]. 中国当代医药, 2021, 28(18): 102-105.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I18/102

[1]	吴素勤，王鹰，舒志明，等.疤痕子宫再次妊娠分娩方式的危险因素分析[J].中国临床药理学杂志，2017，33（7）：662-664.
[2]	赵婷，姚吉龙，刘庆芝，等.血管生长因子及其相关受体与原因不明复发性流产潜在发病机制的研究进展[J].中国优生与遗传杂志，2018，18（2）：126-128.
[3]	高延秋，张华，李双凤.血浆可溶性血管内皮生长因子受体1 在重症肺炎患者中的诊断与预测价值[J].郑州大学学报（医学版），2017，52（1）：63-67.
[4]	魏安华，丁玉峰，彭金兰.血管内皮生长因子受体酪氨酸激酶抑制剂致非小细胞肺癌患者高血压风险Meta 分析[J].药物不良反应杂志，2018，20（1）：30-37.
[5]	吴万民，张文芳，杨义，等.促血管生成素/酪氨酸激酶受体、血管内皮生长因子及其受体信号通路在糖尿病性视网膜病变中的研究进展[J].中国糖尿病杂志，2017，9（4）：258-261.
[6]	陶萍萍，原杰彦，郑伟平，等.宫颈癌、癌旁组织酪氨酸激酶受体B、脑源性神经营养因子、血管内皮生长因子-C及血管内皮生长因子受体-3 的表达[J].中国妇幼保健，2017，32（11）：2462-2466.
[7]	Xie H，Qiao P，Lu Y，et al.Increased expression of high mobility group box protein 1 and vascular endothelial growth factor in placenta previa[J].Mol Med Rep，2017，16（6）：9051.
[8]	胡如艳，陈嘉，王艳菊，等.不同分娩方式对瘢痕子宫再次妊娠产妇及新生儿影响的Meta 分析[J].现代预防医学，2017，44（6）：1023-1027.
[9]	Fan D，Xia Q，Liu L，et al.The Incidence of Postpartum Hemorrhage in Pregnant Women with Placenta Previa：A Systematic Review and Meta-Analysis[J].PLoS One，2017，12（1）：170 194.
[10]	蒋凤芳，李怡澄，赵赛婉，等.疤痕子宫患者再次剖宫产术后产褥感染的危险因素与病原学和耐药性分析[J].中华医院感染学杂志，2017，27（7）：1608-1611.
[11]	Sturzenegger K，Schaffer L，Zimmermann R，et al.Risk factors of uterine rupture with a special interest to uterine fundal pressure[J].J Perinat Med，2017，45（3）：309-313.
[12]	梁欣.剖宫产术后瘢痕子宫再次妊娠阴道试产失败危险因素Logistic回归分析[J].检验医学与临床，2017，14（24）：3693-3695.
[13]	Fan D，Wu S，Liu L，et al.Prevalence of antepartum hemorrhage in women with placenta previa：a systematic review and meta-analysis[J].Sci Rep，2017，7（12）：40 320.
[14]	潘燕梅，刘世良，李秀英.630 例前置胎盘的主体附着位置及疤痕子宫对母儿结局的影响[J].热带医学杂志，2017，17（1）：41-44.
[15]	Zhu Y，Zhang S，Shan W，et al.Feed-forward Control Nursing Model in Expectant Treatment of Placenta Previa[J].Iran J Public Health，2017，46（2）：186.
[16]	臧晓华.二维超声及彩色多普勒对瘢痕子宫合并前置胎盘植入的诊断及临床分析[J].中外医疗，2017，36（21）：174-176.
[17]	陈蓉，黄露.瘢痕子宫合并前置胎盘对孕产妇和新生儿的影响[J].医学临床研究，2018，35（2）：384-385.
[18]	黄静，高志英.子宫切除术在胎盘植入患者临床决策与应用的相关研究[J].中华保健医学杂志，2017，19（6）：513-515.
[19]	傅丹，卢丹，张立英.瘢痕子宫合并前置胎盘的临床特点及其对母婴结局的影响[J].中国妇幼保健，2017，32（17）：4116-4118.
[20]	谭白菊，李玉梅，冯小平.卡前列素氨丁三醇联合葡萄糖酸钙防治瘢痕子宫合并前置胎盘再次剖宫产产后出血的研究[J].中国妇幼健康研究，2017，28（5）：553-555.